MAM
GILD icon

Mystic Asset Management’s Gilead Sciences GILD Stock Holding History

Mystic Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$226K Buy
1,792
+23
+1% +$3.03K 0.05% 211
2026
Q1 		$247K Buy
1,769
+90
+5% +$12.6K 0.06% 207
2025
Q4 		$206K Buy
+1,679
New +$204K 0.05% 212
2022
Q1 		– Sell
-465
Closed -$33K – 247
2021
Q4 		$33K Buy
+465
New +$32K 0.02% 287

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Mystic Asset Management's GILD Position: Q2 2026 in Review

Mystic Asset Management increased its Gilead Sciences (GILD) stake by 1.3% in Q2 2026, buying an estimated $3.03K and bringing the position to 1,792 shares worth $226K. The position accounts for 0.05% of the portfolio, ranked #211.

Mystic Asset Management first reported a position in GILD in Q4 2021 and has held it in 4 quarters since. The position peaked at $247K in Q1 2026. 2,285 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Mystic Asset Management held 1,792 shares of Gilead Sciences worth $226K as of Q2 2026.
  • Mystic Asset Management bought 23 Gilead Sciences shares in Q2 2026, an estimated $3.03K.
  • Gilead Sciences made up 0.05% of Mystic Asset Management's portfolio in Q2 2026, its #211 holding.
  • Mystic Asset Management first reported a position in Gilead Sciences in Q4 2021 and has held it in 4 quarters since.
  • Mystic Asset Management's Gilead Sciences position peaked at $247K in Q1 2026.
  • 2,285 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Mystic Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.